吸烟影响多发性硬化患者对干扰素β的治疗反应
该观察性队列研究纳入834例接受干扰素β治疗的复发缓解型多发性硬化患者,发现吸烟者治疗期间复发率高于不吸烟者(IRR 1.20,95%CI 1.021-1.416,p=0.027),且每日每包香烟使IRR增加27%(IRR 1.27,95%CI 1.056-1.537,p=0.012),未发现与HLA或NAT1变异的关联或交互作用。
要点
- 接受干扰素β治疗的复发缓解型多发性硬化患者中,吸烟者复发率高于不吸烟者(IRR 1.20)。
- 每日每包香烟使复发率比增加27%(IRR 1.27)。
- 未发现吸烟与HLA-DRB1*15:01、HLA-A*02:01或NAT1 rs7388368A的关联或交互作用。
核心结论
- 在这项观察性队列研究中,吸烟与接受干扰素β治疗的复发缓解型多发性硬化患者复发活动增加相关,但未发现与HLA或NAT1变异的关联或交互作用。
研究设计与样本
- 观察性队列研究,从丹麦多发性硬化生物样本库提取834例接受干扰素β治疗的复发缓解型多发性硬化患者DNA进行基因分型。
- 复发信息来自丹麦多发性硬化治疗登记处,涵盖治疗开始前2年至治疗结束或末次随访;吸烟信息来自综合问卷。
主要发现
- 接受干扰素β治疗期间,吸烟者复发率高于不吸烟者,发病率比(IRR)为1.20(95%CI 1.021-1.416,p=0.027)。
- 每日每包香烟使IRR增加27%(IRR 1.27,95%CI 1.056-1.537,p=0.012)。
- 未发现与HLA或NAT1变异的关联或交互作用。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate whether smoking in patients with relapsing-remitting multiple sclerosis (RRMS) treated with interferon beta (IFN-β) is associated with the relapse rate and whether there is an interaction between smoking and human leukocyte antigen (HLA)-DRB1*15:01, HLA-A*02:01, and the N-acetyltransferase-1 (NAT1) variant rs7388368A. METHODS: DNA from 834 IFN-β-treated patients with RRMS from the Danish Multiple Sclerosis Biobank was extracted for genotyping. Information about relapses from 2 years before the start of treatment to either the end of treatment or the last follow-up visit was obtained from the Danish Multiple Sclerosis Treatment Register. Smoking information came from a comprehensive questionnaire. RESULTS: We found that the relapse rate in patients with RRMS during IFN-β treatment was higher in smokers compared to nonsmokers, with an incidence rate ratio (IRR) of 1.20 (95% confidence interval [CI] 1.021-1.416, p = 0.027) and with an IRR increase of 27% per pack of cigarettes per day (IRR 1.27, 95% CI 1.056-1.537, p = 0.012). We found no association or interaction with HLA and the NAT1 variant. CONCLUSION: In this observational cohort study, we found that smoking is associated with increased relapse activity in patients with RRMS treated with IFN-β, but we found no association or interaction with HLA or the NAT1 variant.
引用
- Petersen ER, Oturai AB, Koch-Henriksen N, et al. Smoking affects the interferon beta treatment response in multiple sclerosis. Neurology. 2018. PMID: 29343473. doi:10.1212/WNL.0000000000004949
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。